Although the annual flu vaccine is recommended for all children older than 6 months, about a third of parents say their child won’t receive one this year, according to a new U.S. [Read more]
Tulane University researchers are developing a vaccine formulation that may provide longer lasting immunity in fewer doses against pertussis, more commonly known as “whooping cough.” Microbiologist Lisa Morici, PhD, and immunologist James McLachlan, PhD, [Read more]
Two Live Attenuated Vaccines against Recent Low–and Highly Pathogenic H7N9 Influenza Viruses Are Safe and Immunogenic in Ferrets This paper was originally published in Vaccines and is being distributed by Global Biodefense [Read more]
According to a new survey conducted online by The Harris Poll, commissioned by CareDox and Families Fighting Flu, most Americans (85 percent) understand that otherwise healthy children can die from the flu, [Read more]
The issue of antibacterial resistance is becoming increasingly prevalent within the world of modern medicine. Difficult-to-treat pathogens create an incredibly real issue within clinical environments; and the problem needs to be addressed [Read more]
This Department of Health and Human Services position is located in the newly formed Division of Research, Innovations, and Ventures (DRIVe) within the Biomedical Advanced Research and Development Authority (BARDA), a component [Read more]
It has been 30 years since a new class of antibiotic became available. And resistance has developed to all those that do exist. Last week, the Chief Medical Officer for England, Prof [Read more]
Scientists have discovered that tethering four antibodies together may be an effective strategy for neutralizing all types of influenza virus known to infect humans. The research, published recently in Science, suggests this strategy [Read more]
The U.S. Food and Drug Administration approval in Sep 2018 of the drug Seizalam® (midazolam injection) as an anti-seizure medication, provided the nation with a medical countermeasure (MCM) for people exposed to [Read more]
The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium and the Critical Path Institute (C-Path) Predictive Safety Testing Consortium (PSTC) have received the first ever qualification of a clinical safety [Read more]
© 2018 STEMAR MEDIA